Precision BioSciences prices offering of shares, pre-funded warrants at $7.75 each
DTIL•Precision BioSciences agreed to sell 10,235,077 common shares at $7.75 each and offer warrants for up to 5,893,964 shares at $7.749995 each. The company expects its cash runway to extend into the fourth quarter of 2029.
1. Offering details
Precision BioSciences entered an underwriting agreement on November 5, 2026, to sell 10,235,077 common shares at $7.75 each. The offering also includes pre-funded warrants to purchase up to 5,893,964 common shares at $7.749995 per warrant in lieu of common stock.
2. Expected cash runway
The company expects net proceeds, existing cash, operating discipline and availability under its at-the-market facility to provide a cash runway into the fourth quarter of 2029. It expects the runway to fund the PBGENE-HBV and PBGENE-DMD clinical programs through key next-stage inflection points.
